Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Check your car registration: 5 On Your Side finds hundreds of drivers paying wrong fees
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LOBEF
Recent news which mentions LOBEF
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
News
Psychedelics Reform
IGXT
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
ENVB
Markets
Guidance
From
Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
Tags
News
Next/Generation Psychedelics
LOBEF
From
Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Tickers
AWKNF
CMND
DRUG
HUGE
Tags
TRUFF
Markets
Psychedelics Reform
From
Benzinga
Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up
April 20, 2023
Tickers
LOBEF
Tags
Sickle Cell Disease
News
Rare Diseases
From
Benzinga
Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
February 28, 2023
Tickers
LOBEF
Tags
Benzinga
Lobe Sciences
General
From
Benzinga
Chronic Cluster Headaches, Next Target For This Non-Hallucinogenic Psychedelic
January 27, 2023
Tickers
LOBEF
Tags
Markets
Cannabis
Market News
From
Benzinga
Mass-Scale Psilocin Clinical Supplies Are Ready For Upcoming Trials
October 14, 2022
Tickers
LOBEF
Tags
Market News
Markets
Cannabis
From
Benzinga
Psychedelics Funding At Its Best: $1.5 M Destined To Psilocybin Clinical Trials In Australia
September 01, 2022
Tickers
ATAI
DRUG
LOBEF
Tags
LOBEF
DRUG
Psychedelics
From
Benzinga
This Psychedelic Company Just Signed An Exclusive Deal For Psilocin Clinical Trials In Australia
August 10, 2022
Tickers
LOBEF
Tags
Markets
Cannabis
Market News
From
Benzinga
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change
July 19, 2022
Tickers
LOBEF
MYCOF
Tags
Markets
World Intellectual Property Organization
Dr/ Rakesh Jetly
From
Benzinga
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
June 15, 2022
Tickers
CYBN
ENTBF
FLHLF
JAGX
Tags
LOBEF
Elon Musk
SILFF
From
Benzinga
New Share Consolidation of Lobe Sciences Ltd., Here's What Changes
June 08, 2022
Tickers
CSE
LOBEF
Tags
Cannabis
Market News
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.